J.P. Morgan Life Sciences Private Capital names Bruce N. Rogers venture partner

J.P. Morgan Asset Management named Bruce N. Rogers as venture partner at Life Sciences Private Capital.

• Rogers is president and CEO of a precision immunology portfolio company focused on selectively targeting disease-driving T-cell populations.
• He previously led Morphic Therapeutic, joining as chief scientific officer in 2016 and later serving as president through its $3.2 billion sale to Lilly.
• Rogers later became senior vice president and CEO of Morphic at Lilly, overseeing portfolio and team integration.
• Earlier roles included head of Neuro-Opportunities at Pfizer, following 16 years in medicinal chemistry at Pfizer and Pharmacia.